A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 3, 2004, Pages 182-187

  Goetzl, Manlio A ^a   Goluboff, Erik T ^a   Murphy, Alana M ^a   Katz, Aaron E ^a   Mansukhani, Mahesh ^a   Sawczuk, Ihor S ^b   Olsson, Carl A ^a   Benson, Mitchell C ^a   McKiernan, James M ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Complication rate; Cytoreductive nephrectomy; Renal cell carcinoma; Tumor thrombus

Indexed keywords

ADULT; AGED; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; HUMAN; INFERIOR CAVA VEIN; KIDNEY TUMOR; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; NEPHRECTOMY; PATHOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR THROMBUS; TUMOR VOLUME;

EID: 3242725125     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2004.02.001     Document Type: Article

References (20)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer Statistics, 2004. CA Cancer J Clin. 54:2004;8-29
2. Mickisch G.H.J., Garin A., van Poppel H., de Prijck L., Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal cell carcinoma a randomized trial. Lancet. 358:2001;966-970
3. Yagoda A., Abi-Rached B., Petrylak D. Chemotherapy for advanced renal-cell carcinoma 1983-1993. Semin Oncol. 22:1995;42-60
4. Flanigan R.C., Salmon S.E., Blumenstein B.A., et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 345:2001;1655-1659
5. Zisman A., Pantuck A.J., Chao D.H., et al. Renal cell carcinoma with tumor thrombus is cytoreductive nephrectomy for advanced disease associated with an increased complication rate? J Urol. 168:2002;962-967
6. Guinan P., Sobin L., Algaba F., et al. TNM staging of renal cell carcinoma workgroup No. 3-Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 80:1997;992-993
7. Vaidya A., Ciancio G., Soloway M. Surgical techniques for treating a renal neoplasm invading the inferior vena cava. J Urol. 169:2003;435-444
8. Naitoh J., Kaplan A., Dorey F., Figlin R., Belldegrun A. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. J Urol. 162:1999;46-50
9. Zisman A., Wieder J.A., Pantuck A.J., et al. Renal cell carcinoma with tumor thrombus extension biology, role of nephrectomy and response to immunotherapy. J Urol. 169:2003;909-916
10. Thrasher J.B., Paulson D.F. Prognostic factors in renal cancer. Urol Clin North Am. 20:1993;247-262
11. Ficarra V., Righetti R., D'Amico A., Rubilotta E., Novella G., Malossini G., Mobilio G. Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma. Oncology. 61:2001;10-15
12. Skinner D.G., Pritchett T.R., Lieskovsky G., Boyd S.D., Stiles Q.R. Vena caval involvement by renal cell carcinoma surgical resection provides meaningful long-term survival. Ann Surg. 210:1989;387-394
13. Hatcher P.A., Anderson E.E., Paulson D.F., Carson C.C., Robertson J.E. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol. 145:1991;20-23
14. Neves R.J., Zincke H. Surgical treatment for renal cancer with vena cava extension. Br J Urol. 59:1987;390-395
15. Miyao N., Oda T., Shigyou M., et al. Pre-operatively determined prognostic factors in metastatic renal cell carcinoma. Eur Urol. 31:1997;292-296
16. Belis J.A., Levinson M.E., Pae W.E. Jr. Complete radical nephrectomy and vena caval thrombectomy during circulatory arrest. J Urol. 163:2000;434-436
17. Ciancio G., Hawke C., Soloway M. The use of liver transplant techniques to aid in the surgical management of urological tumors. J Urol. 164:2000;665-672
18. Ljungberg B., Stenling R., Osterdahl B., Farrelly E., Aberg T., Roos G. Vein invasion in renal cell carcinoma impact on metastatic behavior and survival. J Urol. 154:1995;1681-1684
19. Franklin J.R., Figlin R., Rauch J., Gitlitz B., Belldegrun A. Cytoreductive surgery in the management of metastatic renal cell carcinoma the UCLA experience. Semin Urol Oncol. 14:1996;230-236
20. Rackley R., Novick A., Klein E., Bukowski R., McIain D., Goldfarb D. The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma. J Urol. 152:1994;1399-1403